Bioethics Ltd
Bioethics, Ltd. does not have significant operations. It intends to seek investigate and, if warranted, acquire an interest in a business opportunity. Bioethics, Ltd. was incorporated in 1990 and is based in Ogden, Utah.
Bioethics Ltd (BOTH) - Net Assets
Latest net assets as of June 2025: $-931.22K USD
Based on the latest financial reports, Bioethics Ltd (BOTH) has net assets worth $-931.22K USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($14.66K) and total liabilities ($945.88K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-931.22K |
| % of Total Assets | -6350.38% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 48.79 |
Bioethics Ltd - Net Assets Trend (1998–2025)
This chart illustrates how Bioethics Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Bioethics Ltd (1998–2025)
The table below shows the annual net assets of Bioethics Ltd from 1998 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $-931.22K | 0.00% |
| 2024-12-31 | $-931.22K | -19.96% |
| 2023-12-31 | $-776.26K | -14.31% |
| 2022-12-31 | $-679.12K | -15.91% |
| 2021-12-31 | $-585.91K | -22.39% |
| 2020-12-31 | $-478.73K | -30.89% |
| 2019-12-31 | $-365.74K | -36.56% |
| 2018-12-31 | $-267.82K | -45.33% |
| 2017-12-31 | $-184.28K | -53.49% |
| 2016-12-31 | $-120.06K | -8272.52% |
| 2015-12-31 | $-1.43K | +75.55% |
| 2014-12-31 | $-5.87K | +93.85% |
| 2013-12-31 | $-95.31K | -30.95% |
| 2012-12-31 | $-72.79K | -55.72% |
| 2011-12-31 | $-46.74K | -112.78% |
| 2010-12-31 | $-21.97K | -325.14% |
| 2009-12-31 | $-5.17K | -415.67% |
| 2008-12-31 | $-1.00K | -109.26% |
| 2007-12-31 | $10.82K | +59.09% |
| 2006-12-31 | $6.80K | -45.51% |
| 2005-12-31 | $12.48K | +1828.95% |
| 2004-12-31 | $-722.00 | -114.06% |
| 2003-12-31 | $5.14K | -53.43% |
| 2002-12-31 | $11.03K | -31.54% |
| 2001-12-31 | $16.11K | -30.12% |
| 2000-12-31 | $23.05K | -20.87% |
| 1999-12-31 | $29.13K | -15.96% |
| 1998-12-31 | $34.66K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Bioethics Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 144849900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $3.33K | % |
| Other Components | $520.28K | % |
| Total Equity | $-931.22K | 100.00% |
Bioethics Ltd Competitors by Market Cap
The table below lists competitors of Bioethics Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Dayou AutoParts Co. Ltd.
KO:290120
|
$18.36K |
|
Pittler Maschinenfabrik AG
F:PIT
|
$18.37K |
|
Global Masters Fund Ltd
AU:GFL
|
$18.37K |
|
Daybreak Oil and Gas Inc
PINK:DBRM
|
$18.39K |
|
LOLC Holdings PLC
CM:LOLCN0000
|
$18.36K |
|
FGI Industries Ltd. Warrant
NASDAQ:FGIWW
|
$18.35K |
|
Ratu Prabu Energi Tbk
JK:ARTI
|
$18.35K |
|
YANZHOU COAL -H- (YZCA.SG)
STU:YZCA
|
$18.35K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bioethics Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -931,220 to -931,220, a change of 0.
- Net loss of 176,955 reduced equity.
- Other factors increased equity by 176,955.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-176.96K | -19.0% |
| Other Changes | $176.96K | +19.0% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Bioethics Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1998-12-31 | $0.03 | $1.25 | x |
| 1999-12-31 | $0.03 | $1.25 | x |
| 2000-12-31 | $0.02 | $1.25 | x |
| 2001-12-31 | $0.01 | $1.25 | x |
| 2002-12-31 | $0.01 | $1.25 | x |
| 2003-12-31 | $0.00 | $1.25 | x |
| 2004-12-31 | $0.00 | $1.25 | x |
| 2005-12-31 | $0.01 | $1.25 | x |
| 2006-12-31 | $0.01 | $1.25 | x |
| 2007-12-31 | $0.01 | $1.25 | x |
| 2008-12-31 | $0.00 | $1.25 | x |
| 2009-12-31 | $0.00 | $1.25 | x |
| 2010-12-31 | $-0.02 | $1.25 | x |
| 2011-12-31 | $-0.04 | $1.25 | x |
| 2012-12-31 | $-0.07 | $1.25 | x |
| 2013-12-31 | $-0.09 | $1.25 | x |
| 2014-12-31 | $0.00 | $1.25 | x |
| 2015-12-31 | $0.00 | $1.25 | x |
| 2016-12-31 | $-0.02 | $1.25 | x |
| 2017-12-31 | $-0.03 | $1.25 | x |
| 2018-12-31 | $-0.24 | $1.25 | x |
| 2019-12-31 | $-0.33 | $1.25 | x |
| 2020-12-31 | $-0.42 | $1.25 | x |
| 2021-12-31 | $-0.52 | $1.25 | x |
| 2022-12-31 | $-0.60 | $1.25 | x |
| 2023-12-31 | $-0.68 | $1.25 | x |
| 2024-12-31 | $-0.28 | $1.25 | x |
| 2025-12-31 | $-0.62 | $1.25 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bioethics Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-23.16%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1998 | -15.39% | 0.00% | 0.00x | 1.03x | $-8.80K |
| 1999 | -18.98% | 0.00% | 0.00x | 1.02x | $-8.44K |
| 2000 | -26.38% | 0.00% | 0.00x | 1.03x | $-8.39K |
| 2001 | -41.95% | 0.00% | 0.00x | 1.07x | $-8.37K |
| 2002 | -46.07% | 0.00% | 0.00x | 1.07x | $-6.18K |
| 2003 | -114.74% | 0.00% | 0.00x | 1.14x | $-6.41K |
| 2004 | 0.00% | 0.00% | 0.00x | 0.00x | $-5.79K |
| 2005 | -54.43% | 0.00% | 0.00x | 1.00x | $-8.04K |
| 2006 | -228.60% | 0.00% | 0.00x | 1.00x | $-16.33K |
| 2007 | -101.85% | 0.00% | 0.00x | 1.16x | $-12.10K |
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | $-11.72K |
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | $-21.42K |
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $-14.60K |
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $-20.10K |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $-18.77K |
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-13.00K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-207.60K |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-95.42K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-106.62K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-45.79K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-46.76K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-65.34K |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-71.32K |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-48.59K |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-25.29K |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-19.52K |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-83.83K |
| 2025 | 0.00% | 0.00% | 0.00x | 0.00x | $-83.83K |
Industry Comparison
This section compares Bioethics Ltd's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bioethics Ltd (BOTH) | $-931.22K | -15.39% | N/A | $18.36K |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |